ClinicalTrials.gov
public full text
Public Domain
Does Dual Therapy Hasten Antidepressant Response?
This study will utilize a randomized double-blind design to evaluate whether initial treatment with two anti-depressant medications (escitalopram and bupropion) results in more rapid remission and greater over-all remission rates than either monotherapy in 240 depressed subjects.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prevention of Relapse & Recurrence of Bipolar Depression#1128217
- Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD)#1231229
- Comparative Effectiveness of Augmentation, Switching, and Dose Escalation After Inadequate Antidepressant Response in Medicare Beneficiaries#313444
- Cipralex in Treatment of Depressive Symptoms and Chronic Back Pain#1088214
- Escitalopram as a Mood Stabilizer for Bipolar II Disorder#800244
Record · ID 1197283
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive